Drug may slow spread of deadly eye cancer
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to new research at the School of Medicine. Their findings are available online in the journal Clinical Cancer Research.
Legal drinking age linked to women’s suicide, homicide risk
New research by Richard Grucza, PhD, at Washington University School of Medicine in St. Louis shows that a legal drinking age of less than 21 is linked to a higher risk of homicides and suicides among adult women.
Researchers identify gene for rare dementia
Studying family members suspected of having Alzheimer’s disease, researchers at Washington University School of Medicine in St. Louis have identified a gene that causes a rare disorder highlighted by memory loss and motor impairments. The condition is known as Kufs disease, but scientists say the discovery paves the way to development of a genetic test for Kufs and to therapies to treat dementia, which is a hallmark of Kufs and of other neurodegenerative conditions, such as Alzheimer’s disease.
Daily wheezing treatment no different from intermittent in toddlers
Pediatricians often treat young children who have frequent bouts of wheezing with a daily dose of an inhaled steroid to keep asthma symptoms at bay. But results of a recent study by researchers at Washington University School of Medicine, including Leonard B. Bacharier, MD, are likely to change that.
Surprising pathway implicated in stuttering
Researchers at Washington University School of Medicine in St. Louis, including Stuart A. Kornfeld, MD, have obtained new evidence that at least some persistent stuttering is caused by mutations in a gene governing not speech, but a metabolic pathway involved in recycling old cell parts. Beyond a simple association, the study provides the first evidence that mutations affecting cellular recycling centers called lysosomes actually play a role in causing some people to stutter.
New service brings power of genomics to patient care
Genomics and Pathology Services at Washington University School of Medicine in St. Louis (GPS@WUSTL), directed by Karen Seibert, PhD, is now offering a test for mutations in 28 genes associated with cancer. The genes in the test affect a variety of different types of tumors, including blood, lymph, lung, brain, bladder, kidney, skin, stomach, prostate and breast cancers.
School of Medicine Faculty, Staff and Student Art Show call for submissions
The School of Medicine’s 8th Annual Art Show is now accepting submissions through Jan. 13, 2012.
Washington People: Matthew J. Ellis
Breast cancer expert Matthew Ellis, MD, PhD, works with the Genome Institute at Washington University to sequence entire breast cancer genomes — the billions of “letters” making up a person’s DNA. The goal is to unlock the mysteries of breast cancer and tailor treatments to individual patients.
Drug clears chronic urinary infections in mice
An experimental treatment for urinary tract infections has easily passed its first test in animals, alleviating weeks-long infections in mice in as little as six hours.
Probiotic protects intestine from radiation injury
Scientists at Washington University School of Medicine in St. Louis have shown that taking a probiotic before radiation therapy can protect the intestine from damage — at least in mice. Their study suggests that taking a probiotic also may help cancer patients avoid intestinal injury, a common problem in those receiving radiation therapy for abdominal cancers.
Older Stories